HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Manufacture of basic pharmaceutical products
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Manufacture of basic pharmaceutical products
Previous Company Names
Contact & Details
Contact
Registered Address
1 New Burlington Place London W1S 2HR United Kingdom
Full company profile for HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY (05557934), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 8 Sept 2005. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2013–2025)
Cash in Bank
£354.00M
Net Assets
£2606.00M
Total Liabilities
£3065.00M
Turnover
£3380.00M
Employees
N/A
Debt Ratio
54%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Riad Ali Mishlawi | Director | Portuguese | Portugal | 1 Sept 2023 | Active |
See all 29 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
Charges
Charges
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Fifth Floor Offices, 1 New Burlington Place, London (W1S 2HR) CITY OF WESTMINSTER | Leasehold | - | 26 May 2016 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 10 Apr 2026 | Capital | Capital Return Purchase Own Shares | |
| 10 Apr 2026 | Capital | Capital Return Purchase Own Shares | |
| 8 Apr 2026 | Capital | Capital Return Purchase Own Shares | |
| 25 Mar 2026 | Officers | Change to director Ms Victoria Mary Hull on 2025-06-30 | |
| 6 Jan 2026 | Officers | Termination of Mary Regina Henderson as director on 2025-12-31 |
Capital Return Purchase Own Shares
Capital Return Purchase Own Shares
Capital Return Purchase Own Shares
Change to director Ms Victoria Mary Hull on 2025-06-30
Termination of Mary Regina Henderson as director on 2025-12-31
Recent Activity
Latest Activity
Capital Return Purchase Own Shares
1 weeks ago on 10 Apr 2026
Capital Return Purchase Own Shares
1 weeks ago on 10 Apr 2026
Capital Return Purchase Own Shares
1 weeks ago on 8 Apr 2026
Change to director Ms Victoria Mary Hull on 2025-06-30
3 weeks ago on 25 Mar 2026
Termination of Mary Regina Henderson as director on 2025-12-31
3 months ago on 6 Jan 2026